Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7362167

Concept 2023-03-01 to
2023-11-30
2022-03-01 to
2022-11-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
12,480,000,000 JPY
9,821,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
4,644,000,000 JPY
2,928,000,000 JPY
Foreign currency translation adjustment
10,795,000,000 JPY
18,021,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-140,000,000 JPY
-240,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
92,000,000 JPY
-31,000,000 JPY
Other comprehensive income
15,391,000,000 JPY
20,678,000,000 JPY
Comprehensive income
27,871,000,000 JPY
30,499,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
27,392,000,000 JPY
30,104,000,000 JPY
Comprehensive income attributable to non-controlling interests
479,000,000 JPY
395,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.